Skip to content
healthcare.dev

Qsymia

NDC 62541-202, phentermine and topiramate, capsule, extended release, from Vivus LLC.

Product NDC
62541-202
Status
Listed
Labeler
Vivus LLC
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022580
DEA schedule
CIV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62541-202 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PHENTERMINE HYDROCHLORIDE7.5 mg/1
  • TOPIRAMATE46 mg/1

Pharmacologic classes

Appetite Suppression [PE]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Increased Sympathetic Activity [PE]; Sympathomimetic Amine Anorectic [EPC]

Package NDCNDC-11Package
62541-202-306254102023030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (62541-202-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/40dd5602-53da-45ac-bb4b-15789aba40f9

Use it

Look up 62541-202 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62541-202 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62541-202. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.